Biomanufacturing

November 27, 2023

Advancing patient care with biologics: 4 ways Mayo Clinic’s biomanufacturing strategy is making a difference

By Susan Buckles Susan Buckles (@susanbuckles)

Mayo Clinic seeks to harness the power of cells, tissue and genes by delivering first-of-their kind therapeutics for patients in early-stage clinical trials. Mayo Clinic’s Center for Regenerative Biotherapeutics is leading an effort that is at the crossroads of biology, engineering, industry and medicine to expand biomanufacturing for rare and complex disorders. Biomanufacturing is the […]

View full entry

Tags: #biologics, #Dr. Cynthia Wilkins, #Dr. Julie Allickson, #Dr. Snigdha Rai, #Immunotherapies, #Mayo Clinic Center for Regenerative Biotherapetics


November 10, 2023

Unleashing viruses aimed at killing cancer

By Susan Buckles Susan Buckles (@susanbuckles)

During breaks from his doctoral research in London, Richard Vile, Ph.D., would visit a pediatric brain tumor clinic next to his lab for inspiration. Seeing children suffer changed the course of his career, igniting his passion for finding cancer treatments that would be easier for people to tolerate. “I became very, very motivated to try […]

View full entry

Tags: #Cancer, #CAR-T cell therapy, #Dr. Richard Vile, #Mayo Clinic Center for Regenerative Biotherapeutics, #oncolytic virus


September 19, 2023

Harnessing the immune system to fight ovarian cancer

By Susan Buckles Susan Buckles (@susanbuckles)

Mayo Clinic research is biomanufacturing an experimental, cell-based ovarian cancer vaccine and combining it with immunotherapy to study a “one-two punch” approach to halting disease progression in ovarian cancer patients. This research begins with a blood draw from women with advanced ovarian cancer whose tumors have returned after standard surgery and chemotherapy. White blood cells […]

View full entry

Tags: #dendritic cells, #Dr. Keith Knutson, #Dr. Matthew Block, #Mayo Clinic Center for Regenerative Biotherapeutics, #ovarian cancer, #ovarian cancer vaccine


September 1, 2023

A passion for bringing new biotherapeutics to patients

By Susan Buckles Susan Buckles (@susanbuckles)

A yearning to heal patients and excitement for the new and growing field of biotherapeutics are what attracted Wen Lu, M.D., to her new role as medical director of Mayo Clinic’s Center for Regenerative Biotherapeutics in Rochester. Dr. Lu will provide clinical input on which biotherapeutics hold the most promise and should advance to early […]

View full entry

Tags: #biologics, #CAR T-cell therapy, #cell therapy, #Dr. Wen Lu, #Mayo Clinic Center for Regenerative Medicine


July 31, 2023

Driven by family, fueled by hope: Mayo Clinic researcher fights against Type 1 diabetes

By Susan Buckles Susan Buckles (@susanbuckles)

Quinn Peterson, Ph.D., was a graduate student working on a team to develop new chemotherapy drugs when a life-changing phone call reset the course of his career. His daughter, Clarissa, had been diagnosed with Type 1 diabetes. Neither he nor his wife had any known family history of the disease. “Given my background as a […]

View full entry

Tags: #biomedical research, #diabetes research, #Dr. Quinn Peterson, #Islet research, #Mayo Clinic Center for Regenerative Biotherapeutics, #medical research, #Type 1 diabetes


August 15, 2022

Mayo Clinic announces a strategic collaboration for a new era of biomanufacturing

By Susan Buckles Susan Buckles (@susanbuckles)

Mayo Clinic today announced a strategic collaboration in biomanufacturing to deliver novel biotherapeutics for rare and complex conditions. The collaboration brings together science, engineering and manufacturing to advance Mayo Clinic’s vision of bringing new cures to clinical care. The focus will be on therapies derived from human sources known as biologics — cells, blood, enzymes, […]

View full entry

Tags: #biologics, #cell therapy, #Dr. Julie Allickson, #gene therapy, #Mayo Clinic Center for Regenerative Medicine, #National Resilience Inc.


August 2, 2022

Options for laryngeal regeneration

By Susan Buckles Susan Buckles (@susanbuckles)

Mayo Clinic is using 3D printing as a new option to heal the larynx after cancer or traumatic injury. David Lott, M.D., a Mayo Clinic otolaryngologist and head and neck surgeon, is an expert who can speak about a pioneering procedure using 3D bioimplants and tissue engineering to regenerate the larynx, more commonly known as […]

View full entry

Tags: #Dr. David Lott, #laryngeal cancer, #laryngectomy, #larynx transplant, #Mayo Clinic Center for Regenerative Medicine, #Tissue engineering


July 11, 2022

Bringing regenerative technology of the future to patients today

By Susan Buckles Susan Buckles (@susanbuckles)

“The sky’s the limit,” “possibility” and “potential cure for disease” are aspirational ways Mayo Clinic physicians and scientists described regenerative medicine in a recent virtual presentation at the World Stem Cell Summit 2022. Mayo’s panel discussion showcased how it is advancing regenerative medicine through industry collaborations that accelerate scientific discoveries to early stage clinical trials. […]

View full entry

Tags: #Dr. Abba Zubair, #Dr. David Lott, #Dr. Julie Allickson, #Dr. Saranya Wyles, #Mayo Clinic Center for Regenerative Medicine, #World Stem Cell Summit


June 27, 2022

Biomanufacturing 101: Understanding a new era of therapeutics

By Susan Buckles Susan Buckles (@susanbuckles)

Advancing cellular discoveries from clinical trials to commercial therapy is a cornerstone of Mayo Clinic’s strategic emphasis on biomanufacturing. The long-term vision is to provide new cures for patients with unmet needs. “Biomanufacturing is a type of manufacturing that utilizes sources from the human body — cells, blood, enzymes, tissues, genes or genetically engineered cells […]

View full entry

Tags: #biologics, #biotherapeutics, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Medicine, #stem cell research


June 13, 2022

Addressing the challenges of chimeric antigen receptor-T cell therapy

By centerforregmedmc centerforregmedmc (@centerforregmedmc)

Article by Marla Broadfoot Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) — a type of immunotherapy that reprograms a patient’s T cells to recognize and destroy cancer cells — has revolutionized the treatment of blood cancers. While the technique has successfully sent patients with advanced disease into remission, it is far from perfect. CAR-T […]

View full entry

Tags: #CAR T-cell therapy, #Dr. Hong Qin, #Dr. Saad Kenderian, #Mayo Clinic Center for Regenerative Medicine, #regenerative immunotherapy


Contact Us · Privacy Policy